GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

“Gratitude is one of the most medicinal emotions we can feel.” (Sara Avant Stover) Thank you for joining GRACE in our #LCAM15 activities.

Direct download: GRACEcast-407_LCAM_2015_What_Are_You_Grateful_For.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

Dr. Jack West reviews the Lung Cancer Master Protocol for second line treatment of patients with advanced squamous NSCLC, an "umbrella protocol" in which all patients undergo molecular testing and have treatment assigned by the results.

Direct download: GRACEcast-402_LCAM_2015_West_SWOG1400_Lung_MAP.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

Dr. Ross Camidge talks about a clinical trial that will test to see if the drug tesevatinib will work to kill cancer that has progressed in the brains of EGFR-mutant lung cancer patients. The trial is scheduled to begin in late 2015 or early 2016.

Direct download: GRACEcast-406_LCAM_2015_Camidge_Kadmon_EGFR_Brain_Mets_Trial.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

On this Thanksgiving Day, we salute lung cancer patient Jason Karg and his wife Kristyl for reminding us of the important things in life. November is Lung Cancer Awareness Month. What are you grateful for?

Direct download: GRACEcast-382_LCAM_2015_Karg_Sickness_Health.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve outcomes in patients who receive immunotherapy for advanced lung cancer.

Direct download: GRACEcast-404_LCAM_2015_West_Epigenetic_Priming_Immunotherapy.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung cancer patients may be eligible. http://bit.ly/UCponatinib


Dr. Seema Nagpal insists on one thing from her lung cancer patients: Proof that they are enjoying their lives. November is Lung Cancer Awareness Month. What are you grateful for?

Direct download: GRACEcast-381_LCAM_2015_Nagpal_Patient_Postcards.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

Dr. Jack West reviews treatment options for patients with an EGFR activating mutation and acquired resistance but no T790M mutation, focusing on a clinical trial with the novel hypoxia-induced pan-HER inhibitor TH4000.

Direct download: GRACEcast-401_LCAM_2015_West_T790M_Neg_TH4000_Trial.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT

Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.


Drs. Ben Solomon, Leora Horn, & Jack West assess the utility and limitations of "liquid biopsies", serum-based testing for molecular marker testing in lung cancer.